Should I Buy BSX Stock in 2026?

Data-driven analysis and honest assessment for Boston Scientific Corp

Analysis Updated:
CAUTIONSeveral concerns warrant careful consideration

Current Price: $76.85P/E: 39.0

Decision Score

4.6/10

Weak

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)3/10

High P/E of 39.0 indicates premium

Growth (20%)5/10

Slow growth of 0%

Profitability (20%)4/10

Thin margins (0% net)

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)6/10

Decent FCF yield of 3.3%

Insider Activity (10%)5/10

No recent insider activity

Key Investment Metrics

Current Price

$76.85

P/E Ratio

39.05

Revenue Growth

0.2%

Profit Margin

0.1%

Market Cap

$112.4B

Dividend Yield

None

How BSX Compares to Competitors

Understanding how BSX stacks up against peers helps inform your investment decision.

How BSX Compares to Peers

Upcoming Events for BSX

+5 Reasons TO Buy BSX

1. High gross margins of 69%

moderate

Gross margins above 50% typically indicate strong brand value or intellectual property moats.

2. Large-cap stability and market leadership

moderate

With market cap over $100B, this company has established leadership and resources to weather cycles.

-5 Reasons NOT to Buy BSX

1. Thin profit margins of 0.1%

high risk

Low margins provide little cushion against cost increases or pricing pressure.

2. Premium valuation at 39x earnings

medium risk

P/E of 39 requires sustained growth to justify. Multiple compression risk exists.

3. Minimal revenue growth

low risk

Growth of 0.2% barely keeps pace with inflation.

Who Should Buy BSX?

Investment Profile

Risk Level

Medium

Recommended Holding Period

3-5 years

Best For:

    Not Suitable For:

    • Growth Investors

      Limited 0% growth may disappoint

    • Value Investors

      Premium P/E of 39 doesn't fit value criteria

    • Income-Focused Retirees

      No dividend paid

    Consider These Alternatives

    If you're interested in BSX, compare these Health Care peers:

    Pro tip: Compare BSX directly with competitors using our comparison tool to see which stock better fits your criteria.

    Get the Full Picture

    Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for BSX

    Frequently Asked Questions

    What is BSX stock price today?

    BSX (Boston Scientific Corp) stock is trading at $76.85 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

    Is BSX stock going up or down today?

    BSX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

    Should I buy BSX stock now?

    The decision to buy BSX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

    Is BSX a buy, hold, or sell right now?

    Our AI-powered analysis provides buy/hold/sell recommendations for BSX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

    Is BSX stock overvalued or undervalued?

    BSX currently trades at a P/E ratio of 39.05, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if BSX is fairly priced.

    What is BSX's P/E ratio?

    BSX has a price-to-earnings (P/E) ratio of 39.05, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

    What is BSX's market cap?

    BSX (Boston Scientific Corp) has a market capitalization of $112.40 billion, making it a mid-cap stock.

    What is BSX's price to book ratio?

    BSX trades at a price-to-book (P/B) ratio of 6.36, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

    Similar Investment Decisions

    Explore investment analyses for stocks similar to Boston Scientific Corp

    Explore Categories

    Disclaimer

    This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.